the present invention relates to multi component composition of dronedarone or pharmaceutically acceptable salts , esters , metabolites , prodrugs or enantiomers thereof and controlled release polymers . the use of multi component composition of dronedarone would improve the bioavailability and the patient compliance with reduction in number of dosages to be taken per day .